Kalunian, K. C., Furie, R., Morand, E. F., Bruce, I. N., Manzi, S., Tanaka, Y., . . . Al‐Mossawi, H. (2023). A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus. Arthritis & Rheumatology, 75(2), 253-265. https://doi.org/10.1002/art.42392
Citace podle Chicago (17th ed.)Kalunian, Kenneth C., et al. "A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus." Arthritis & Rheumatology 75, no. 2 (2023): 253-265. https://doi.org/10.1002/art.42392.
Citace podle MLA (9th ed.)Kalunian, Kenneth C., et al. "A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus." Arthritis & Rheumatology, vol. 75, no. 2, 2023, pp. 253-265, https://doi.org/10.1002/art.42392.